Pomerantz LLP is investigating claims on behalf of investors of  Tempus AI, Inc. ("Tempus" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

TheStreet. On May 28, Tempus AI stock plunged as the market reacted to a damning report from short seller Spruc ...

An independent safety board has endorsed the continuation of BioXcel Therapeutics, Inc.'s (NASDAQ: BTAI) pivotal Phase 3 SERENITY At-Home trial evaluating BXCL501 for agitation tied to bipolar ...

In this video, I will talk about Tempus AI (NASDAQ: TEM) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock ...

Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report ...

The concept of AI in healthcare is no longer a novelty, experts are acknowledging AI algorithms, detection, and drug ...

U.S.-based Tempus AI came under intense pressure after a scathing short seller report raised red flags about the company’s valuation, business model, and financial transparency.

Live Updates Live Coverage Updates appear automatically as they are published. Wall Street Analyst Moves 10:09 am by Gerelyn ...

Live Updates Live Coverage Updates appear automatically as they are published. Stocks in Focus 10:29 am by Bank of America ...

After a three-year drought, the industry is questioning whether the window for medtech public offerings is open following a ...

The short-sale attack on Tempus AI (TEM) heated up on Wednesday. The stock’s rally halted after it lost 19.23% to close at ...